Impact of target lesion coronary calcification on stent expansion – An optical coherence tomography study –

Circulation Journal

Volumn 78, Issue 9, 2014, Pages 2209-2214

  Kobayashi, Yuhei ^a   Okura, Hiroyuki ^a   Kume, Teruyoshi ^a   Yamada, Ryotaro ^a   Kobayashi, Yukari ^a   Fukuhara, Kenzo ^a   Koyama, Terumasa ^a   Neishi, Yoji ^a   Hayashida, Akihiro ^a   Kawamoto, Takahiro ^a   Yoshida, Kiyoshi ^a   Nezuo, Shintaro ^b  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b Kawasaki Hospital   (Japan)

Author keywords

Coronary artery disease; Drug eluting stents; Optical coherence tomography

Indexed keywords

GLYCERYL TRINITRATE; HEPARIN;

AGED; ANGIOCARDIOGRAPHY; ARTERY LESION; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY CALCIUM SCORE; CORRELATION ANALYSIS; DRUG ELUTING CORONARY STENT; FEMALE; HEART CATHETERIZATION; HUMAN; MALE; MEDICAL PARAMETERS; MINIMAL STENT AREA; MINIMAL STENT DIAMETER; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; RETROSPECTIVE STUDY; ROTABLATOR; STENT UNDEREXPANSION; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DRUG ELUTING STENT; FOLLOW UP; MIDDLE AGED; PATHOLOGY; PROCEDURES; VASCULAR CALCIFICATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CORONARY ARTERY DISEASE; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR CALCIFICATION;

EID: 84906807334     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-0108     Document Type: Article

References (24)

1. Stone GW, Teirstein PS, Meredith IT, Farah B, Dubois CL, Feldman RL, et al. A prospective, randomized evaluation of a novel everolimuseluting coronary stent: The PLATINUM (a Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of Up to Two de Novo Coronary Artery Lesions) trial. J Am Coll Cardiol 2011; 57: 1700-1708.
2. De la Torre Hernandez JM, Garcia Camarero T, Lerena P, Lee DH, Sainz Laso F, Gorria GM, et al. A real all-comers randomized trial comparing Xience Prime and Promus Element stents. J Invasive Cardiol 2013; 25: 182-185.
3. Danzi GB, Chevalier B, Urban P, Fath-Ordoubadi F, Carrie D, Wiemer M, et al. Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: The NOBORI 2 study. EuroIntervention 2012; 8: 109-116.
4. Kadota K, Muramatsu T, Iwabuchi M, Saito S, Hayashi Y, Ikari Y, et al. Randomized comparison of the Nobori biolimus A9-eluting stent with the sirolimus-eluting stent in patients with stenosis in native coronary arteries. Catheter Cardiovasc Interv 2012; 80: 789-796.
5. Cutlip DE, Baim DS, Ho KK, Popma JJ, Lansky AJ, Cohen DJ, et al. Stent thrombosis in the modern era: A pooled analysis of multicenter coronary stent clinical trials. Circulation 2001; 103: 1967-1971.
6. Uren NG, Schwarzacher SP, Metz JA, Lee DP, Honda Y, Yeung AC, et al. Predictors and outcomes of stent thrombosis: An intravascular ultrasound registry. Eur Heart J 2002; 23: 124-132.
7. Sonoda S, Morino Y, Ako J, Terashima M, Hassan AH, Bonneau HN, et al. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: Serial intravascular ultrasound analysis from the sirius trial. J Am Coll Cardiol 2004; 43: 1959-1963.
8. Fujii K, Mintz GS, Kobayashi Y, Carlier SG, Takebayashi H, Yasuda T, et al. Contribution of stent underexpansion to recurrence after sirolimus- eluting stent implantation for in-stent restenosis. Circulation 2004; 109: 1085-1088.
9. Takebayashi H, Kobayashi Y, Mintz GS, Carlier SG, Fujii K, Yasuda T, et al. Intravascular ultrasound assessment of lesions with target vessel failure after sirolimus-eluting stent implantation. Am J Cardiol 2005; 95: 498-502.
10. Fujimoto H, Nakamura M, Yokoi H. Impact of calcification on the long-term outcomes of sirolimus-eluting stent implantation: Subanalysis of the Cypher Post-Marketing Surveillance Registry. Circ J 2012; 76: 57-64.
11. Fujii K, Carlier SG, Mintz GS, Yang YM, Moussa I, Weisz G, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: An intravascular ultrasound study. J Am Coll Cardiol 2005; 45: 995-998.
12. de Ribamar Costa J Jr, Mintz GS, Carlier SG, Fujii K, Sano K, Kimura M, et al. Intravascular ultrasound assessment of drug-eluting stent expansion. Am Heart J 2007; 153: 297-303.
13. de Ribamar Costa J Jr, Mintz GS, Carlier SG, Mehran R, Teirstein P, Sano K, et al. Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloon. Am J Cardiol 2007; 100: 812-817.
14. He Y, Maehara A, Mintz GS, Bharaj H, Castellanos C, Kesanakurthy S, et al. Intravascular ultrasound assessment of cobalt chromium versus stainless steel drug-eluting stent expansion. Am J Cardiol 2010; 105: 1272-1275.
15. Kume T, Okura H, Kawamoto T, Yamada R, Miyamoto Y, Hayashida A, et al. Assessment of the coronary calcification by optical coherence tomography. EuroIntervention 2011; 6: 768-772.
16. Kume T, Okura H, Miyamoto Y, Yamada R, Saito K, Tamada T, et al. Natural history of stent edge dissection, tissue protrusion and incomplete stent apposition detectable only on optical coherence tomography after stent implantation: Preliminary observation. Circ J 2012; 76: 698-703.
17. Bezerra HG, Attizzani GF, Sirbu V, Musumeci G, Lortkipanidze N, Fujino Y, et al. Optical coherence tomography versus intravascular ultrasound to evaluate coronary artery disease and percutaneous coronary intervention. JACC Cardiovasc Interv 2013; 6: 228-236.
18. Yabushita H, Bouma BE, Houser SL, Aretz HT, Jang IK, Schlendorf KH, et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation 2002; 106: 1640-1645.
19. Kume T, Akasaka T, Kawamoto T, Watanabe N, Toyota E, Neishi Y, et al. Assessment of coronary arterial plaque by optical coherence tomography. Am J Cardiol 2006; 97: 1172-1175.
20. Tearney GJ, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra HG, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: A report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol 2012; 59: 1058-1072.
21. Morino Y, Honda Y, Okura H, Oshima A, Hayase M, Bonneau HN, et al. An optimal diagnostic threshold for minimal stent area to predict target lesion revascularization following stent implantation in native coronary lesions. Am J Cardiol 2001; 88: 301-303.
22. Takano Y, Yeatman LA, Higgins JR, Currier JW, Ascencio E, Kopelson KA, et al. Optimizing stent expansion with new stent delivery systems. J Am Coll Cardiol 2001; 38: 1622-1627.
23. Mehanna E, Bezerra HG, Prabhu D, Brandt E, Chamie D, Yamamoto H, et al. Volumetric characterization of human coronary calcification by frequency-domain optical coherence tomography. Circ J 2013; 77: 2334-2340.
24. Kawasaki T, Koga H, Serikawa T, Orita Y, Ikeda S, Mito T, et al. Impact of a prolonged delivery inflation time for optimal drug-eluting stent expansion. Catheter Cardiovasc Interv 2009; 73: 205-211.